Roche Cancer Drug Suffers Patent Setback in India

Published: Aug 06, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

India has partly revoked patents granted to a Roche Holding AG breast cancer medicine, the Swiss firm said on Sunday, in the latest regulatory setback for western drugmakers trying to crack the fast-growing market. A Roche spokesman said the company was considering what further course of action to take. The Kolkata Patent Office said on Monday the company had failed to file its patent applications for Herceptin correctly and the patents had not been revoked.

Help employers find you! Check out all the jobs and post your resume.

Back to news